244 related articles for article (PubMed ID: 30918147)
21. Clinical outcomes of pneumocystis pneumonia from a tertiary care centre in Pakistan.
Sarwar Zubairi AB; Shahzad H; Zafar A
J Pak Med Assoc; 2016 Nov; 66(11):1367-1371. PubMed ID: 27812050
[TBL] [Abstract][Full Text] [Related]
22. Pneumocystis jirovecii pneumonia in Latin America. A public health problem?
Calderón EJ; de Armas Y; Panizo MM; Wissmann G
Expert Rev Anti Infect Ther; 2013 Jun; 11(6):565-70. PubMed ID: 23750728
[TBL] [Abstract][Full Text] [Related]
23. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection.
Enomoto T; Azuma A; Kohno A; Kaneko K; Saito H; Kametaka M; Usuki J; Gemma A; Kudoh S; Nakamura S
Respirology; 2010 Jan; 15(1):126-31. PubMed ID: 19947989
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of Pneumocystis jirovecii colonization among HIV-positive patients in southern Brazil.
Pereira RM; Müller AL; Zimerman RA; Antunes DB; Zinn VF; Friaza V; de la Horra C; Calderón EJ; Wissmann G
Med Mycol; 2014 Nov; 52(8):804-9. PubMed ID: 25288653
[TBL] [Abstract][Full Text] [Related]
25. Retrospective study of Pneumocystis pneumonia over half a century in mainland China.
Wang XL; Wang XL; Wei W; An CL
J Med Microbiol; 2011 May; 60(Pt 5):631-638. PubMed ID: 21273373
[TBL] [Abstract][Full Text] [Related]
26. Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial.
Qin Y; Lu Y; Zhou Y; Harypursat V; Sun F; Yang S; Tang S; Li Y; He X; Zeng Y; Chen Y
Trials; 2020 Jun; 21(1):551. PubMed ID: 32571429
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of
Dunbar A; Schauwvlieghe A; Algoe S; van Hellemond JJ; Reynders M; Vandecasteele S; Boelens J; Depuydt P; Rijnders B
Front Cell Infect Microbiol; 2020; 10():224. PubMed ID: 32500040
[No Abstract] [Full Text] [Related]
28. Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005).
Kelley CF; Checkley W; Mannino DM; Franco-Paredes C; Del Rio C; Holguin F
Chest; 2009 Jul; 136(1):190-197. PubMed ID: 19255292
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy.
Yang L; Xia P; Zhou Y; Cui Q; Chen G; Zheng K; Qin Y; Li X
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2305-2314. PubMed ID: 34047874
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Pneumocystis jirovecii pneumonia at three tertiary comprehensive hospitals in southern China.
Chen YH; Fang XY; Li YT; Liu YL; Hang YP; Xiao YP; Cao XW; Zhong QS; Hu LH
Braz J Microbiol; 2020 Sep; 51(3):1061-1069. PubMed ID: 32363569
[TBL] [Abstract][Full Text] [Related]
31. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
[TBL] [Abstract][Full Text] [Related]
32. [An epidemiologic study on Pneumocystis pneumonia in non-HIV infected patients in China].
Sun L; Huang MJ; An YJ; Guo ZZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Apr; 30(4):348-51. PubMed ID: 19731525
[TBL] [Abstract][Full Text] [Related]
33. Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates.
Nakashima K; Aoshima M; Ohkuni Y; Hoshino E; Hashimoto K; Otsuka Y
J Infect Chemother; 2014 Dec; 20(12):757-61. PubMed ID: 25187511
[TBL] [Abstract][Full Text] [Related]
34. Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases.
Braga BP; Prieto-González S; Hernández-Rodríguez J
Med Clin (Barc); 2019 Jun; 152(12):502-507. PubMed ID: 30853123
[TBL] [Abstract][Full Text] [Related]
35. Use of Induced sputum to determine the prevalence of Pneumocystis jirovecii in immunocompromised children with pneumonia.
Das CK; Mirdha BR; Singh S; Seth R; Bagga A; Lodha R; Kabra SK
J Trop Pediatr; 2014 Jun; 60(3):216-22. PubMed ID: 24425204
[TBL] [Abstract][Full Text] [Related]
36. Spatiotemporal Clusters and Trends of Pneumocystis Pneumonia in Korea.
Kim HS; Nam HW; Ahn HJ; Lee SH; Kim YH
Korean J Parasitol; 2022 Oct; 60(5):327-338. PubMed ID: 36320109
[TBL] [Abstract][Full Text] [Related]
37. Pneumocystis jirovecii Pneumonia.
Catherinot E; Lanternier F; Bougnoux ME; Lecuit M; Couderc LJ; Lortholary O
Infect Dis Clin North Am; 2010 Mar; 24(1):107-38. PubMed ID: 20171548
[TBL] [Abstract][Full Text] [Related]
38. [Pneumocystis Pneumonia in 107 HIV Infected Patients Admitted to the Department of Infectious Diseases at Santa Maria Hospital, Lisbon (2002 - 2013)].
Grilo V; Pereira A
Acta Med Port; 2016 Oct; 29(10):639-650. PubMed ID: 28103460
[TBL] [Abstract][Full Text] [Related]
39. Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment.
Roblot F; Le Moal G; Kauffmann-Lacroix C; Bastides F; Boutoille D; Verdon R; Godet C; Tattevin P;
Scand J Infect Dis; 2014 Mar; 46(3):210-4. PubMed ID: 24450839
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia.
Lanaspa M; O'Callaghan-Gordo C; Machevo S; Madrid L; Nhampossa T; Acácio S; de la Horra C; Friaza V; Campano E; Alonso PL; Calderón EJ; Roca A; Bassat Q
Clin Microbiol Infect; 2015 Nov; 21(11):1018.e9-1018.e15. PubMed ID: 26231980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
